http://www.fda.gov/cder/orange/appendix_a.txt 3, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE PHOSPHATE #3, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE PHOSPHATE, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE, ACETAMINOPHEN ACETAMINOPHEN, ACETAMINOPHEN (OTC) ACETAMINOPHEN, ASPIRIN AND CAFFEINE, ACETAMINOPHEN (OTC) ACETAMINOPHEN, ASPIRIN, AND CODEINE PHOSPHATE, ACETAMINOPHEN ACETAMINOPHEN, BUTALBITAL AND CAFFEINE, ACETAMINOPHEN ACETAMINOPHEN,...
MATERIAL SAFETY DATA SHEET page 1
author: Linda
MATERIAL SAFETY DATA SHEET page 1
author: Linda
Prescription and Over-the-Counter Drug Product List: 3/2003 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE CAPSULE; ORAL FIORICET W/ CODEINE -D- AB + NOVARTIS 325MG;50MG;40MG;30MG N20232 001 JUL 30, 1992 MAR CAHN -A- AB + WATSON PHARMS 325MG;50MG;40MG;30MG N20232 001 JUL 30, 1992 MAR CAHN ACETAMINOPHEN; CODEINE PHOSPHATE TABLET; ORAL CODRIX -A- + ANDRX PHARMS 500MG;30MG N40441 001...
author: AUTHOR
Prescription and OTC Drug Product List 5/2001 IRRIGANT NYSTATIN - ADD - MONARCH PHARMS EQ 40MG BASE/ML; - ADD - @ TEVA 100,000 UNITS/GM N61966 001 - ADD - 200,000 UNITS/ML N60707 001 OINTMENT; TOPICAL - DLT - NILSTAT NETILMICIN SULFATE - DLT - AT + LEDERLE 100,000 UNITS/GM N61444 001 - ADD - @ 100,000 UNITS/GM N61444 001 - DLT - INJECTABLE; INJECTION NYSTATIN - DLT - NETROMYCIN - DLT - AT ALTANA 100,000 UNITS/GM N62124 002 - DLT...
Document 10944 Federal Register / VolN - hexane at specified temperatures Maximum soluble fraction (expressed as percent by weight of polymer) in xylene at specified...
author: U.S. Government Printing Office
subject: Extracted Pages
MATERIAL SAFETY DATA SHEET page 2
author: Linda
MATERIAL SAFETY DATA SHEET page 2
author: Linda
#79103: Fura-Zone Fura-Zone Nitrofurazone Soluble Dressing Description Fura-Zone Ointment is indicated for the prevention or treatment of surface bacterial infections of wounds, burns, and cutaneous ulcers.Nitrofurazone 0.2% Water soluable base of polyethylene glycols q.s.
Prescription and OTC Drug Product List 9/2002 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST -A- ADEFOVIR DIPIVOXIL -A- TABLET; ORAL -A- HEPSERA -A- + GILEAD 10MG N21449 001 SEP 20, 2002 SEP NEWA ALBUTEROL SULFATE TABLET, EXTENDED RELEASE; ORAL -A- ALBUTEROL SULFATE -A- AB SIDMAK LABS EQ 4MG BASE N76130 002 SEP 26, 2002 SEP NEWA -A- AB EQ 8MG BASE N76130 003 SEP 26, 2002 SEP NEWA VOLMAX -D- BC + MURO EQ 4MG BASE N19604...
Prescription and OTC Drug Product List 6/2002 -A- + GD SEARLE LLC EQ 500MG BASE/VIAL N18353 001 JUL CAHN -D- + SCS EQ 500MG BASE/VIAL N18353 001 JUL CAHN MIDAZOLAM HYDROCHLORIDE INJECTABLE; INJECTION MIDAZOLAM HCL -A- AP ABBOTT EQ 1MG BASE/ML N75857 001 JUL 22, 2002 JUL NEWA -A- AP EQ 5MG BASE/ML N75857 002 JUL 22, 2002 JUL NEWA MIDODRINE HYDROCHLORIDE TABLET; ORAL PROAMATINE -A- + SHIRE LABS 5MG N19815 002 SEP 06, 1996 JUL CRLD...
Untitled Document DECLARATION OF PROF
Products - General Formulations About Us l-Products-l Marketing Network l Exports & Imports l- Careers -l- Research -l- Partnerships -l Ne ws l Sitemap l Search - - Products Biologicals Dewormers General -- Formulations Other Group ...
Medicines, Ethics and Practice page 9
Prescription and OTC Drug Product List 2/2001 PEDIATRIC - ADD - @ 10MG;100MG N74080 001 - ADD - + ASTRAZENECA /1VIL;0.02MG/VIAL;0.001MG/VIAL; - ADD - MAR 25, 1994 - ADD - 5MG/VIAL;0.01MG/VIAL;0.14MG/VIAL; - ADD - @ 25MG;100MG N74080 002 - ADD - 17MG/VIAL;0.2MG/VIAL; - ADD - MAR 25, 1994 - ADD - EQ 1MG BASE/VIAL;1.4MG/VIAL; - ADD - @ 25MG;250MG N74080 003 - ADD - EQ 1.2MG BASE/VIAL;0.7MG/VIAL; - ADD - MAR 25, 1994 - ADD - 7MG...
WAIS Document Retrieval [Federal Register: October 8, 1998 (Volume 63, Number 195)] [Proposed Rules] [Page 54082-54089] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr08oc98-22] ======================================================================= ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug...
WAIS Document Retrieval [Federal Register: March 8, 1999 (Volume 64, Number 44)] [Rules and Regulations] [Page 10944-10947] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr08mr99-12] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Part 216 [Docket No
Annex II Antibiotic Resistance in the European Union Associated with Therapeutic use of Veterinary Medicines Report and Qualitative Risk Assessment by the Committee for Veterinary Medicinal Products Annex II Antibiotics used in Human Medicine in the EU (Table 11) ...
author: EMEA
Annex II page 4 Annex II (February 1999) Public ãEMEA 1999 3/ 3 Target / Agent Mode of Use Spectrum Authorised in vet. med. Related Compound Giving Cross- Resistance b) Tetracyclines Tetracycline Oxytetracycline Minocycline Doxycycline o o iv, o iv, o Broad Broad Broad Broad Yes Yes No Yes Other tetracyclines Phenicols ...
author: EMEA
Antibiotic Resistance in the Eupean Union Associated with Ther page 107 Committee for Veterinary Medicinal Products Annex II (February 1999) Public ãEMEA 1999 3/ 4 Target / Agent Mode of Use Spectrum Authorised in vet. med. Related Compound Giving Cross- Resistance b) Tetracyclines Tetracycline Oxytetracycline Minocycline Doxycycline o o iv, o iv, o Broad Broad Broad Broad Yes Yes No Yes Other tetracyclines Phenicols ...
author: EMEA-CVMP
subject: Committee for Veterinary Medicinal Products
http://www.emea.eu.int/pdfs/vet/mrls/nitrofurans.pdf The European Agency for the Evaluation of Medicinal Products 7 Westferry Circus, Canary Wharf, London E14 4HB, UK Tel: (+ 44- 171) 418 84 00 Fax: (+ 44- 171) 418 84 16 COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS NITROFURANS SUMMARY REPORT 1. Nitrofurazone and furazolidone were discussed at the 40th ...
author: Jerry Wells
http://www.emea.eu.int/pdfs/vet/mrls/nitrofurans.pdf page 1 The European Agency for the Evaluation of Medicinal Products 7 Westferry Circus, Canary Wharf, London E14 4HB, UK Tel: (+ 44- 171) 418 84 00 Fax: (+ 44- 171) 418 84 16 COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS NITROFURANS SUMMARY REPORT 1. Nitrofurazone and furazolidone were discussed at the 40th ...
author: Jerry Wells
Document page 4
author: U.S. Government Printing Office
subject: Extracted Pages
Document 54082 Federal Register / VolNitrofurazone: All drug products containing nitrofurazone (except topical drug products formulated for dermatalogic application)
author: U.S. Government Printing Office
subject: Extracted Pages
Document page 7
author: U.S. Government Printing Office
subject: Extracted Pages
duplicates:http://www.fda.gov/cder/fdama/10898.pdf
